Blog
-
-
Medtronic’s rechargeable neurostimulator implant nets FDA approval for bladder and bowel control
-
Ofatumumab May Beat Older Drug at Preventing MS Relapse
-
Novartis says CAR-T cancer therapy works in second lymphoma type
-
FDA clears Zebra Medical’s breast cancer AI for spotting suspicious mammography lesions
-
Does Spinraza provide benefit after treatment with Novartis’ gene therapy Zolgensma? Biogen aims to find out
-
Spark, chasing BioMarin, plans 2021 start for key hemophilia gene therapy study
-
Orphan Drug Exclusivity Keeps Biosimilars Off the Market, Study Says
-
5 FDA approval decisions to watch in the 3rd quarter
-
Appeals judges quash HHS rule requiring drug prices in TV ads